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The characterization of the antigen-recognizing structure on the various classes of 
T  cells has been a difficult problem for immunologists. Three aspects of this problem 
are  particularly  controversial:  first,  whether  the  genes  that  code  for  the  variable 
portion  of  immunoglobulin  also  code  for  the  antigen-recognizing  portion  of  the 
receptor on all classes of T  cells  (1-4);  second, whether T  cell receptors specific for 
allo-major histocompatibility complex (MHC) 1 products are unique or are included 
within  the population of receptors for conventional  antigens  (5-10);  and third, how 
T  cells, particularly those of the cytotoxic and helper classes, are able to demonstrate 
an  apparent  dual  specificity for both a  conventional  antigen  and a  product  of the 
MHC  such  that  they  function  only  when  confronted  with  both  the  appropriate 
antigen  and MHC product  (11-16).  Various models have been proposed to explain 
this  phenomenon.  Some  have  proposed  that  antigen  and  MHC  are  recognized 
independently via two receptors on the T  cell (17-23). Others have proposed various 
forms of dependent  recognition,  involving, for example, a  single receptor on the T 
cell, and/or  a  physical interaction between antigen  and MHC products in antigen- 
presenting cells (24-26). A number of experimental results have been used by various 
investigators to argue for one or the other of these models, but there is little evidence 
that distinguishes the various possibilities. 
A direct attack on these questions has been hampered by the lack of suitable sources 
of clonal T  cell lines analogous to the B cell myelomas. Recently, two techniques have 
offered promise in this regard. The first is the establishment of long-term cultures of 
normal antigen-specific T cells through the use of repeated in vitro antigen stimulation 
and/or the growth factor, interleukin 2 (IL-2; formerly, T  cell growth factor) (27-30). 
The second  is  the  production  of immortal T  cell hybrids between  normal antigen- 
specific T  cells and T  cell tumor lines  (31-36).  In the present  study,  we combined 
these  two  methods  to produce  inducible,  antigen-specific, H-2-restricted T  cell  hy- 
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bridomas.  Four cloned hybridoma cell  lines  were  produced.  Each grew rapidly  in 
culture without stimulation but produced IL-2 in response to a challenge with specific 
antigen and splenic antigen-presenting cells of the appropriate H-2 haplotype. In each 
case,  the H-2-restricting element  mapped  to  the  I  region.  One of the  hybrid  lines 
responded to an allo-H-2 determinant .as well. 
In addition, we used this fusion method to produce hybrids between cells  that had 
different  antigen~H-2  specificities.  These  "double"  hybrids  often  maintained  the 
ability to recognize both parental  antigen~H-2  combinations, but  no hybrids were 
detected with either of the "cross-specificities", i.e.,  the H-2 specificity of one parent 
and the antigen specificity of the other. This result offers conclusive evidence against 
any models for H-2 restriction that  predict  the independent  recognition of antigen 
and H-2. 
Materials and Methods 
Mice.  B6D2F1, B6AF1, C57BL/10.SgSn  (BI0),  B10.A, BI0.D2,  and  B10.BR  mice  were 
purchased from The Jackson Laboratory, Bar Harbor, Maine.  The following mice were bred 
in our facility from breeding triplets purchased from The Jackson Laboratory or kindly supplied 
by various  individuals,  as  indicated:  BALB/cJ, CBA/J,  D1.LP,  DBA/2,  B10.A(5R)  (The 
Jackson Laboratory); BALB.B (Dr. M. Bevan, Massachusetts  Institute of Technology, Boston, 
Mass.);  BI0.A(4R), B10.S (Dr. J.  Stimpfling,  McLaughlin  Research  Institute,  Great  Falls, 
Mont.);  B 10.M (Dr. M. Cherry, The Jackson Laboratory); B 10.AQR, B 10.LG (Dr. C. David, 
The  Mayo  Clinic,  Rochester,  Minn.);  B10.TL,  B10.S(7R) (Dr. D.  Shreffler,  Washington 
University,  St. Louis, Mo.);  B10.A(3R), D2.GD, B10.HTT (Dr. D. Sachs, National Institutes 
of Health, Bethesda, Md.). 
Antigens and Other Reagents.  The following antigens  were purchased  from Sigma Chemical 
Co.,  St.  Louis, Mo.:  chicken  ovalbumin (OVA),  pigeon  OVA, turkey  OVA, and beef heart 
cytochrome c (cyto c). The apo form of cyto c was prepared according to a modification of the 
silver sulfate method (37), and its 1-65 peptide was derived by cyanogen bromide cleavage and 
gel filtration  (38). Duck OVA was obtained from Pentex, Division of Miles Corp., Kankakee, 
Ill.  Keyhole  limpet  hemocyanin  (KLH)  was  purchased  from  Calbioehem-Behring  Corp., 
American Hoesehst Corp., San Diego, Calif. Human gammaglobulin (HGG) was purified from 
American Red Cross Cohn Fraction II by DEAE cellulose chromatography. Concanavalin A 
(Con A), hypoxanthine, aminopterin,  and thymidine (HAT), ouabain (OU), and 8-azaguanine 
(AG) were also obtained from Sigma Chemical  Co. Polyethylene glycol (PEG)  1540 and 6000 
were obtained from theJ. T. Baker Chemical Co., Philipsburg,  Pa. PEG-1540 was used at 50% 
wt/wt and PEG-6000 was used at 40% wt/wt. 
Immunizations.  Mice were immunized with 100 #g of antigen emulsified in complete Freund's 
adjuvant at the base of the tail, except in the case of apo cyto c, when 50 #g/mouse was used 
(39). Para-aortie and inguinal  lymph nodes were taken 7 d later. 
Tissue Culture Media.  Primary lymph node cultures  were  established  in  Click's  medium 
containing 1% syngeneic normal mouse serum  (NMS)  (40). Otherwise,  cells were cultured in 
medium prepared according to Mishell and Dutton (41), but modified to contain 5 ×  10  -5 M 
2-mercaptoethanol,  10% fetal calf serum  (pre-selected to support primary spleen cell responses 
to sheep erythrocytes  in Mishell-Dutton  cultures),  50-100 #g/ml gentamicin  (Shering Corp., 
Kenilworth,  N. J.), and  10% Misheil-Dutton  nutrient cocktail. This medium is referred  to as 
complete  medium. 
IL-2 Production.  Bulk IL-2 containing supernatant fluids (SN) was prepared using the Con 
A-inducible  hybridoma, FS6-14.13 (42). Hybrid cells were  cultured  at  5  ×  10s-106/ml  in 
complete medium containing 4/~g/ml Con A. After 24 h, the cells were removed by centrifu- 
gation, and the SN were passed through a sterile 0.2-/~ filter and stored at -20°C. Occasionally, 
Con A-induced SN of rat spleen cell cultures were used as a source of IL-2 (40). 
To test hybrids for the antigen-specific stimulation  of IL-2, production cultures were prepared 
containing l0  B  hybrid cells/ml,  antigen at the appropriate concentration,  and 5 X 10  n irradiated 1200  T  CELL  HYBRIDS WITH ONE  OR TWO ANTIGEN/H-2  SPECIFICITIES 
(4,000 rad) spleen cells/ml of the appropriate 11-2 type. After 24 h, the SN were tested for the 
presence of IL-2. 
Assay for  1L-2.  The T  cell growth-stimulating activity of IL-2 was assayed with a  semi- 
quantitative method using the IL-2-dependent T cell line HT-2 (kindly provided by Dr. James 
Watson, University of California, Irvine, Calif.). As originally described,  this was a  cloned 
helper T  cell line that grew continuously in IL-2 (30). The subline used in these experiments 
had lost its helper activity, but maintained its absolute requirement for IL-2 for viability and 
growth. Within 24 h of removal from IL-2, the HT-2 cells were >95% dead. In the continuous 
presence of IL-2, this cell line had a viability of >95%. Therefore, to test an SN for the presence 
of IL-2, 0.1-ml cultureswere prepared containing  various dilutions of the SN or of a known IL- 
2-containing  standard SN. These cultures received 0.01 ml of Mishell-Dutton nutrient cocktail 
(41) and 4,000 viable HT-2 cells. Control cultures contained no IL-2. After 24 h, the cultures 
were examined with an inverted phase microscope. Cultures containing  <5% viable cells were 
scored negative (-). Cultures with 90-100% viable cells were scored positive (+). Cultures with 
5-90% viable cells were scored intermediate (:t:). 
The data  are  presented  as  the  results obtained with  80%  SN;  however,  titrations were 
performed in most experiments, especially in the characterizations of the cloned hybrids. In 
these  cases,  nearly  all  positive  SN  had  titers  >1:10.  Negative  SN  were  negative  at  all 
concentrations tested. 
This assay for IL-2 has the advantage of being extremely rapid because cultures can be 
screened visually for IL-2 presence only 24 h  after plating. We have compared it on many 
occasions with more routine methods of measuring IL-2 concentrations, such as stimulation of 
tritiated thymidine incorporation by IL-2-dependent T  cell blasts. The two techniques give 
very similar results. 
Hybridoma  Antibody  Reagents.  To aid in the I  region mapping of specificity of our T  cell 
hybridomas, we used a  number of hybridoma anti-I-A reagents produced by this and other 
laboratories (43). These are listed with their relevant properties in Table I. We are extremely 
grateful  to  Drs.  L.  Herzenberg and  L.  Herzenberg and  their  colleagues for  making their 
hybridomas available to  the scientific community via The Salk Institute Cell Distribution 
Center, La Jolla, Calif. The hybridoma antibodies produced in this laboratory were mapped to 
I-A using B cells from the appropriate H-2 recombinant mice.  Other laboratories using these 
reagents have confirmed the specificities. 
Parent  T  Cell Tumor Lines for Fusions.  Four related parental T  cell tumor lines were used in 
these studies. The first  two were derived from the Con A-inducible T  cell hybridoma, FS6- 
14.13 (42). FS6-14.13 cells were grown in 10  -4 MAG. Most of the hybrid cells died within the 
next  few  days, but over a  period of weeks  the cultures were overgrown by surviving cells 
resistant to the drug. These cells were cloned at limiting dilution and the resultant clones were 
tested both for sensitivity to HAT and for IL-2 production after Con A stimulation. One clone, 
FS6-14.13.AG2, was selected for use in fusions. In one case, a subclone of FS6-14.13.AG2, which 
had been selected for resistance to both AG and 10  -3 M  OU, was used as the tumor parent. 
This subcline was called FS6-14.13.AG2.OUS. 
In one of the fusions described in the results, the hybrid AO-40 was produced; this hybrid 
could be stimulated to produce IL-2 by either Con A, 1-1-2  b cells, or OVA plus H-2 a cells. Two 
parental lines suitable for use in fusions were derived from AO-40. The first was produced by 
TABL~ I 
L A  Specific Hybridoma Antibodies  Used in  These Studies 
Normal parent 
Hybrid  Tumor parent  Immuno-  Specificity  Class  Reference 
Strain  gen 
11-5.2  NS-1  BALB/c  CKB  1-A k  y2b, x  Oi et al. (43) 
10-3.6  NS-1  CWB  C3H  1-A v~';r  y2a, x  Oi et al. (43) 
MK-D6  P3X63-AG8.653  (B6 × A/J)F1  BI0.D2  LA  d  Unknown  This paper 
MK-S4  45.6TG1.7  (D1.LP × B10.A)FI  B10.S  1-A  ~t  Unknown  This paper KAPPLER, SKIDMORE, WHITE, AND  MARRACK  1201 
reintroducing AG resistance into AO-40 before cloning. These cells  (AO-40/AG) rapidly lost 
their ability to respond to 1-1-2  b or to OVA plus 14-2  ~, but not to Con A. This uncloned line was 
used as the T cell tumor parent in one fusion. Another parental line was established from AO- 
40.10,  a clone of AO-40. AG resistance was reintroduced into this line and the resultant cells 
were cloned to yield AO-40.10.AG1. This  line continued to respond to 1"1-2  b,  to OVA plus 
1-1-2  ~, and to Con A. It was used in fusions aimed at producing hybrids with two antigen~H-2 
specificities. 
Parental Normal T Cells for Fusions.  A population of normal T  cell blasts highly enriched in 
antigen-specific cells was prepared by the method of Schrier et al.  (40).  Briefly, lymph node 
cells were taken from immunized mice and cultured at 4 ×  106/ml for 4 d with specific antigen 
(125  pg/ml  OVA,  10 #g/ml  KLH,  or 50 #g/ml  apo cyto c  1-65 peptide).  These  cultures 
contained a high concentration of T  cell blasts. Viable cells were isolated on Ficoll-Hypaque 
gradients and were recuitured for 3-4 d at an initial concentration of 105 cells/ml in medium 
containing 50% IL-2 SN. The viable T  cell  blasts were then reisolated and  used  in fusions. 
Previous experiments had shown that this procedure resulted in a T cell preparation ~ 100-fold 
enriched over the initial lymph node cells in specific T cell helper activity or proliferative ability 
(40). 
Fusion Protocol.  Cells were fused essentially by the method of Kontiainen et al.  (33). Both 
PEG-1540 and PEG-6000 were used. In these experiments, -4 ×  l0  T  T cell blasts were fused to 
1-2 ×  107 FS6-14.13.AG2, FS6-14.13.AG2.OU8, AO-40/AG, or AO-40.10.AG1 cells. Cells were 
plated in -300-400 microculture wells in 0.1 ml of medium. HAT was added at 24 h and the 
medium was changed about every 5 d. Hybrid growth was first apparent at about 10 d and the 
last wells were scored positive for growth at about  3 wk.  Hybrids were transferred  to larger 
vessels  to obtain  enough cells  for testing  and  were eventually  "weaned"  off HAT in  HT- 
containing medium. 
Cloning of Hybrid  Cells.  Hybridomas  were  cloned  at  limiting  dilution  in  four  96-weU 
microculture  plates  containing,  on  the  average,  0.125,  0.25,  0.5,  and  1.0  cells/well.  When 
possible, functional clones were selected from the plate having the fewest  clones. At no time 
were clones selected from a plate containing more than 20 clones (2.4% chance of more than 
one clone/well). Cloning efficiencies  varied considerably. 
Results 
Production  of Hybrid~ with an Antigen/I Region Specificity.  To produce antigen-specific, 
H-2-restricted  T  cell  hybridomas,  we  fused  the  Con  A-inducible,  IL-2-producing 
hybridoma FS6-. 13.AG2 (or its derivatives,  FS6-14.13.AG2.OU8 and AO-40/AG) to 
a population of normal T  cell blasts highly enriched in antigen-specific, H-2-restricted 
cells. We used this approach for two reasons. First, the fact that the tumor cell partner 
in the fusions already carried a  function meant that it had to acquire only an antigen 
specificity from the normal T  cell parent. Second, we greatly increased the probability 
of a successful hybrid by enrichment of the normal T  cell parents for antigen-reactive 
cells.  This approach has been highly successful. The four cloned T  cell hybridomas 
that  we  have  produced  thus  far  with  specificity  for antigen  and  an  I  region  gene 
product are described below. 
A0-40.10.  T  cell blasts  enriched  in chicken OVA-specific T  cells were prepared 
from B10.A (H-2 ~) mice and fused to FS6-14.13.AG2 using PEG-6000. Eventually, 11 
hybrids were recovered and tested for IL-2 production in response to a challenge with 
OVA  and  irradiated  B10.A  spleen  cells.  Only  one  responsive  hybrid,  AO-40,  was 
found.  This  hybrid was cloned at  limiting dilution,  and  12  of the  13  clones picked 
and retested were positive for IL-2 production in response to chicken OVA plus B 10.A 
cells.  One  clone,  AO-40.10,  was chosen  for further  characterization.  AO-40.10  has 
been in existence for more than 6 mo, and has been recloned twice. In each recloning, 
the majority of subclones were responsive to OVA plus B 10.A but some unresponsive 1202  T  CELL  HYBRIDS  WITH  ONE  OR  TWO  ANTIGEN/H-2  SPECIFICITIES 
subclones were also found. We therefore established a large frozen stock of the hybrid 
immediately after cloning and routinely replaced the laboratory stock once a month. 
AO-40.10 has a doubling time in culure of ~ 12 h and a cloning efficiency approaching 
100%. 
The fine antigen  specificity of AO-40.10  was determined  using a  series of related 
OVA from chicken, duck, pigeon, and turkey and B 10.A antigen-presenting cells. The 
results, shown  in Table  II, were somewhat  surprising,  in that  AO-40.10  responded 
only  to chicken  OVA  despite  the  fact  that  in  the  lymph  node  proliferation  assay, 
chicken OVA-primed B 10.A cells responded equally well to chicken, duck, and turkey 
OVA (Table III). Apparently AO-40. I0 is specific for a determinant unique to chicken 
OVA. AO-40.10 has also been tested for reactivity against a panel of 30 other antigens 
in  the  presence  of B10.A  antigen-presenting  cells.  Antigens  tested  included  KLH, 
human  and  other species'  gammaglobulin,  cytochrome  c, etc.  In  no case was IL-2 
production induced (results not shown). 
The H-2 specificity of AO-40.10 was established using chicken OVA and irradiated 
antigen-presenting  cells  from a  panel  of H-2  congenic  and recombinant  mice.  The 
results are shown in Table IV.  When  tested with H-2 congenic mice, the surprising 
result  was  obtained  that  AO-40.10  responded  to  all  mice  of the  H-2 b  haplotype 
regardless of background and without the need for the specific antigen, OVA. Among 
the recombinant mice, this OVA-independent  response was seen with B 10.A(3R)  and 
B10.A(5R),  but  not  with B10.A(4R)  or D2.GD,  mapping  this  unexpected  allo-H-2 
response to the K-I-A region of H-2 b. 
TABLE  II 
Antigen Specificity of Cloned T Cell Hybrids 
Hybrid  Irradiatedcells  spleen  Antigen  IL-2 tionPr°duc- 
AO-40.10  B 10.A  Chicken OVA  + 
Duck OVA 
Turkey OVA 
Pigeon OVA 
KLH 
HGG 
AODK-I.16  B10.D2  KLH  + 
Chicken OVA 
HGG 
AODK- 10.4  B 10.D2  KLH  + 
Chicken OVA 
HGG 
DC- 1.18.3  BALB/c  Apo beef cyto c  + 
Native beef cyto c 
KLH 
Chicken OVA 
HGG 
All SN were tested at 80% with HT-2 cells. In tests with AO-40.10, the various 
OVA were used at 250/~g/ml. In other cases, chicken OVA was used at  1,250 
/ag/ml. KLH was used at  1,000/zg/ml. Apo beef cyto c, native beef cyto c, and 
HGG were used at 500 p,g/ml. KAPPLER, SKIDMORE, WHITE, AND MARRACK 
TABLE III 
Specificity of the Proliferative Response of Chicken 0 VA-primed Lymph Node 
Cells from B IO.A Mice 
Lymph node cell [nil]- 
Priming antigen  Challenge  antigen  TdR incorporation on 
day 5 
cpm/culture ×  10  -~ 
Chicken OVA  Chicken OVA  162 :t: 2 
Chicken OVA  Turkey OVA  174 :t: 5 
Chicken OVA  Duck OVA  154 "4- 4 
Chicken OVA  Pigeon OVA  10 -4- 2 
Chicken OVA  Human IgG  2 :t: 1 
Turkey OVA  Turkey OVA  176 :l: 13 
Duck OVA  Duck OVA  163 :l: 2 
Pigeon OVA  Pigeon OVA  217 :l: 4 
Mice were immunized as described in Materials and Methods. Lymph node 
cells were challenged in vitro with antigen and their proliferation was measured 
by [aH]TdR incorporation as described (39, 44). Antigens were used at 250 
#g/ml. Incorporation shown is experimental value minus no antigen control 
value. 
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As expected, AO-40.10 mounted an OVA-dependent  response with cells carrying 
the I region from H-2 k. No OVA-dependent cross-reactions were seen with other H-2 
haplotypes.  Among  the  recombinant  mice,  the  response  with  B10.A,  B10.A(4R), 
B10.TL, and B10.AQR, but not with B10.S(7R),  B10.HTT, or D2.GD, mapped the 
relevant I region gene(s) to LA k. 
The  I  region  molecules  important  in  the  response  of  AO-40.10  were  further 
identified  in  blocking experiments with  anti-LA  hybridoma  antibodies  (Table V). 
The response to OVA plus H-2 a was inhibited by I-A k-specific hybridoma antibodies 
but  not  by  antibodies  to  I-A 8J or I-A d.  That  these  reagents  inhibited  by specific 
blocking  rather  than  by  killing  the  antigen-presenting  cells  was  shown  using  F1 
antigen-presenting  cells.  In  this  case,  antibodies  directed  against  the  inappropriate 
I-A molecule on the F1 cells had no effect on the response. Therefore, the combination 
of genetic mapping and anti-Ia inhibition  mapped the 1t-2 region that is important 
in the OVA-dependent response to I-A h. 
The responses of AO-40.10 to H-2 b and to OVA plus I-A ~ are closely associated. In 
every cloning of this hybrid, each clone has had either both responses (36 clones) or 
neither (15 clones). We consider this point further in the Discussion. 
DC-I. 18.3.  T  cell blasts enriched in apo beefeyto c-specific T  cells were prepared 
from  BALB/e  (H-2 a)  mice  and  fused  to  FS6-14.13.AG2.OU8  using  PEG-1540. 
Eventually,  10 hybrids were recovered and tested for IL-2 production in response to 
a  challenge with apo beef cyto c and irradiated BALB/c spleen cells. All  10 hybrids 
were responsive. The hybrids were frozen and two were picked for cloning attempts. 
One failed to yield functional  clones.  However, of the  16 clones obtained  from the 
other hybrid (cloning efficiency, 24%), one of these, DC- 1.18, was found to be positive. 
DC-1.18 was reeloned (cloning efficiency, 80%) and -60% of the clones were positive. 
One  subelone,  DC-1.18.3,  was  selected  for  further  characterization.  The  antigen 
specificity of DC-1.18.3 was tested with a number of antigens and BALB/c irradiated 
spleen cells (Table II). The hybrid responded to apo beef eyto e, but not to the native 1204 
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TABLE  V 
Anti-I-A Inhibition of the Response of Cloned T Cell Hybrids 
1205 
Hybrid  Stimulus 
IL-2 production 
Hybridoma antibody inhibitor 
No 
Inhibitor  11-5.2  10-3.6  MK-D6  MK-S4 
(I-A  k  )  (I-A  ~t~  )  (La d  )  (I-A  ~t) 
AO-40.10 
AODK- 1.16 
AODK-10.4 
AOFK-11.11.1 
BI0.A + OVA  +  -  -  +  + 
BI0  +  +  +  +  + 
B6D2F1  +  +  +  +  + 
(B10.A ×  D2)F~ + OVA  +  -  -  +  + 
B10.D2 +  KLH  +  +  +  +  + 
B6D2F~ +  KLH  +  +  +  +  + 
(BI0.A X D2)Ft +  KLH  +  +  +  +  + 
B 10.D2 +  KLH  +  +  +  -  + 
B6D2Fa +  KLH  +  +  +  -  + 
(B10.A ×  D2)Fa +  KLH  +  +  +  -  + 
B10.A +  OVA  +  -  -  +  + 
BI0.M +  KLH  +  +  -  +  - 
BI0  +  +  +  +  + 
(BI0 ×  B10.M)F~  +  +  +  +  + 
(BI0.A X BI0.LG)F~  + OVA  +  -  -  +  + 
All SN were tested at 80% with HT-2 cells. Chicken OVA was used at 1,250/~g/ml.  KLH was used at 1,000 
#g/ml. Hybridoma antibodies were added to irradiated stimulator cells and antigen 1 h before the addition 
of the hybridoma cells. Antibodies were added  in the form of 1% ascitic fluid taken from hybridoma- 
containing mice. 
form of the protein.  The fine specificity of this hybrid correlated with that of apo beef 
cyto c  primed  lymph  node  cells in proliferative in  vitro responses  (45).  As expected, 
the hybrid  failed to respond  to chicken OVA,  HGG,  or KLH. 
The  fine  H-2  specificity  of DC-1.18.3  was  determined  using  a  number  of H-2 
congenic  and  recombinant  mice  (Table  IV).  No  response  was  seen  with  any  H-2 
haplotype  in the absence of apo cyto c. There was an apo cyto c-dependent  response 
with  all H-2 a mice tested.  This  reactivity was  mapped  to LA d by  the response  seen 
with D2.GD,  and the lack of response with B 10.LG and  B 10.A. 
A ODK-10. 4 and A ODK- 1.16.  T  cell blasts were prepared from KLH-primed  DBA/ 
2  mice (H-2  a)  and were fused to AO-40/AG  using PEG-1540.  Eventually,  13 hybrids 
were recovered and  tested  for IL-2 production  in response  to  a  challenge with KLH 
and  B10.D2  spleen  cells.  Three  reactive hybrids  were  found  and  cloned  at  limiting 
dilution.  The  first, AODK-9,  failed to yield any  functional  clones and  the uncloned 
line lost reactivity over a  period of weeks.  All clones of the second hybrid, AODK-10, 
(cloning efficiency,  14%)  responded  to  KLH  with  B10.D2  cells.  One  clone, AODK- 
10.4, was selected for further study.  The third hybrid, AODK-1,  had a  poorer cloning 
efficiency, (-7%)  and yielded only one responsive clone of the five tested. This clone, 
AODK-1.16,  was used in these studies. 
Both  AODK-10.4  and  AODK-I.16  were  tested  with  B10.D2  cells  and  several 
antigens.  Both  responded  to  KLH,  but  no  response  was  seen  with  OVA  or  HGG 1206  T  CELL HYBRIDS WITH ONE OR TWO ANTIGEN/H-2 SPECIFICITIES 
(Table II). The H-2 specificities of these hybrids were determined as above with H-2 
congenic and recombinant mice. No antigen-independent response was seen with any 
H-2 haplotype. KLH-specific responses were seen with all three H-2 d strains, but not 
with any other tested H-2 haplotype. Using H-2 recombinant mice, neither hybrid 
responded to KLH with B10.A or B10.LG mice, mapping their specificity to the I 
region. However, AODK-10.4 responded to KLH with D2.GD cells, whereas AODK- 
1.16 did not. This mapped the response of AODK-10.4 to I-A a, but left the subregion 
specificity of AODK-1.16 in doubt. Although the response pattern apparently mapped 
the  specificity to  I-J/LE d,  this  pattern  was  also  consistent  with  specificity  for  a 
composite  molecule  with  elements  from  I-A a  and  I-E/C a  (46).  We  attempted  to 
confirm  the  specificity of these  hybrids  again  using  specific  hybridoma  anti-/-A 
antibodies to inhibit their recognition (Table V). Whereas AODK-10.4 was inhibited 
in its response to KLH plus H-2 a by an anti-/-A d antibody, the response of AODK- 
1.16 was unaffected. Again, the specificities of these inhibitions were established using 
F~ antigen-presenting irradiated spleen cells. Therefore, the combination of the genetic 
mapping and anti-Ia inhibition identified a product ofLA a as the structure recognized 
by AODK-10.4 and left open the possibilities that AODK-1.16 recognized either a 
product of the I-J/I-E region or a molecule with elements from both I-A and I-E/C. 
Production  of Hybrids with  Two Antigen/I Region Specificities.  Next, we attempted to 
produce hybrids with two antigen~H-2 specificities. Using PEG-1540, AO-40.10.AG 1 
was fused to normal T  cell blasts of a different antigen/H-2 specificity. The resultant 
hybrid lines were tested for IL-2 production in response to the four combinations of 
OVA, the second antigen, H-2 a, and the second H-2 type. 
The results of three fusions of this type are summarized in Table VI.  On  initial 
screening, a  large proportion of the hybrids retained reactivities to both OVA plus 
H-2 a and to the normal T  cell parent antigen/H-2 combination. For example, in the 
AOFK fusion, five out of seven hybrid lines tested responded to H-2 ~ plus OVA, and 
H-2 r plus KLH. However, in no case were any hybrids responsive either to OVA plus 
the normal T  cell H-2 type or to H-2 ~ plus the antigen for which the normal T  cell 
parent was specific. This result argued strongly against  the independent recognition 
TABLE VI 
T Cell Hybrids with Two Antigen~H-2 Specificities (Initial Screening) 
Tumor cell  Normal T  cell parent  Number of 
Fusion 
hybrids 
parent  Strain  H-2  Antigen 
IL-2 production 
Reactivity pattern with H-2 +  antigen combinations 
H-2" +  OVA  H-2  d +  HGG  H-2" +  HGG  H-2  d +  OVA 
AODH  AO-40.I0.AG1  DBA/2  d  HGG  2  .... 
1  +  -  -  - 
1  -  +  -  - 
3  +  +  -  -- 
H-2  ~ +  OVA  H-2  r +  KLH  H-2  ° +  KLH  H-2  f +  OVA 
AOFK  AO-40.10.AG 1  BI0.M  f  KLH  2  -  +  -  - 
5  +  +  --  -- 
H-2" +  OVA  H-2  d +  KLH  H-2" +  KLH  H-2  ~ +  OVA 
DKAO  AO.40.10.AGI  BI0.D2  d  KLH  2  +  -  -  - 
1  -  +  -  - 
12  +  +  --  -- 
H-2  ~, H-2  t, and H-2  a cells used in IL-2 production were from BI0.A, BI0.M, and BI0.D2 mice, respectively. SN were tested at 80% on HT-2 
cells. HGG concentration: 500 #g/mL KLH concentration: 500 #g/ml. OVA concentration:  1,250 #g/ml. KAPPLER,  SKIDMORE,  WHITE, AND MARRAGK  1207 
of H-2 and antigen in these hybrids; however, the isolation of clones from the doubly 
reactive hybrids was an essential requirement for this conclusion. This proved to be 
a formidable task. 
As might be expected, because these hybrids resulted from multiple fusions, they 
were unstable. Of the 20 hybrid lines with double specificity listed in Table VI, we 
attempted to clone six. Five of these hybrids yielded clones that had lost the response 
to the antigen/H-2  combination of the normal T  cell parent, whereas most of the 
clones retained the OVA plus H-2 a reactivity. However, a few doubly specific clones 
were obtained from the sixth hybrid, AOFK- 1  I. One clone, AOFK- 1 I. 11, was selected 
and then recloned, yielding many doubly specific clones. Because the establishment 
of clonality is essential to our conclusion concerning the lack of independent 11-2 and 
antigen recognition, the details of the cloning records of AOFK-11 are listed in Table 
VII. None of the clones or subclones of AOFK- 11 showed any reactivity to OVA with 
H-2  f or to KLH with H-2 ~. 
Subclone AOFK- 11.11.1  was selected for further characterization. The reactivity of 
this  hybrid  was  tested  with  OVA  and  KLH  and  a  bank  of H-2  congenic  and 
recombinant mice. The results are listed in Table VIII. AOFK-11.11.1  retained the 
fine 11-2 specificity of the AO-40.10 parent.  An  antigen-independent  response was 
obtained with H-2 b. An OVA-dependent response was seen only with strains bearing 
I-A k.  A  KLH-dependent response was  seen  only with  H-2  r cells.  Surprisingly,  no 
response was seen with KLH and  B 10.LG cells. Although the exact origin of the I 
region of B10.LG is obscure, it is thought to be very similar, if not identical (at least 
serologically), to the I  region of H-2  f  (Dr. C. David, personal communication). This 
would apparently map the H-2f-restricting specificity of AOFK- 11.11.1  outside the I 
region. However, this conclusion was not supported by the results of anti-I-A inhibition 
studies.  To confirm the  mapping  studies  shown  in  Table III,  we  used  hybridoma 
antisera directed at various I-A haplotypes to inhibit antigen presentation to AOFK 
11.11.1.  Our  results  are  shown  in  Table  V.  As  was  the  case  with  AO-40.10,  the 
response of AOFK-11. I 1.1 to OVA plus H-2 was specifically inhibited by hybridoma 
anti-I-A antibodies directed against I-A k (43). The response of AOFK- 1 I. 11.1 to KLH 
plus H-2  f was inhibited by two anti-I-A r hybridomas,  10-3.6 (43)  and MK-S4. The 
MK-S4 hybridoma was prepared in our laboratory from mice immunized with H-28 
cells.  Its  specificity  was  mapped  to  I-A ~  using  a  panel  of the  appropriate  11-2 
recombinant mice. It was found to cross-react with B10.M  (H-2  r) and with B10.LG. 
In both B10.S and B10.M, it reacted with 50-60% of spleen cells and  75-80% of B 
cells, but not with splenic T  cells. Its inhibition of the response of AOFK-11.11.1  to 
KLH plus B 10.M strongly implicated the I-A r molecule as the recognition structure. 
A  control anti-I-A d hybridoma, MK-D6, failed to inhibit H-2 a plus OVA, H-2 b, or 
11-2  r plus KLH presentation. 
Controls using F1 antigen-presenting cells with this and other hybrids showed that 
inhibitions caused by the antibodies were due to specific I-A blocking rather than, for 
example, cytotoxic effects on the antigen-presenting cells, because the antibodies had 
no effect when directed against inappropriate I-A molecules on FI antigen-presenting 
cells. 
Discussion 
We  developed a  method  for producing T  cell  hybridomas  that  responded  to  a 
challenge with specific antigen by producing the lymphokine, IL-2. In each case, the 1208  T CELL HYBRIDS WITH ONE OR TWO  ANTIGEN/H-2 SPECIFICITIES 
TAI3LE VII 
Cloning of AOFK-I 1 
Hybrid 
Tested  Number of  Number of  IL-2 production reactivity patterns 
cells  Number  wells with  clone  plated/  of wells  growth  H'2a +  H'2f +  H'2~ +  H-2f + 
number  well  OVA  KLH  KLH  OVA 
AOFK-  11 
AOFK- 11.11 
.1 
12 
.7 
.9 
.10 
.11 
.12 
.13 
.15 
•16. 
"17  t  .19 
.20 
.21 
,23 
.1 
.I0 
.11 
.12 
.13 
• 141 
.15 
.17 
.20: 
.231 
.241 
.2Y 
.2ff 
,27! 
0.125  96  1  +  -  -  - 
+  NT*  -  - 
0.25  96  5 
4-  ~  -- 
+  -  NT  NT 
4-  ±  -  - 
4-  4-  -  _ 
0.50  96  18 
4-  :t:  -  - 
NT  -  NT  NT 
-  -  -  NT 
4-  4-  -  _ 
1.00  96  18  .... 
4-  --  --  __ 
4-  --  --  -- 
+  + 
+  + 
0.125  96  7  +  + 
+  + 
+  + 
+  ± 
0.25  96  6  +  + 
+  + 
+ 
+  ± 
+  + 
+  ± 
O.5  96  15  +  + 
+  + 
+  + 
+ 
+  ± 
q 
w 
B 
H-2 a and 11-2  b cells used in IL-2 production were from BI0.A and B10.M mice, respectively. SN were 
tested at 80% on HT-2 cells. KLH concentration: 500 #g/ml. OVA concentration:  1,250 #g/ml. 
* Not tested. 
hybrids  responded  to  antigen  only  when  it  was  presented  by  irradiated  splenic 
antigen-presenting  cells of the  appropriate  1"1-2 haplotype.  In  three  cases, the  relevant 
1-1-2 molecule  mapped  to  the  I-A region.  In the  fourth,  the  mapping  of the  relevant  I 
region  molecules  was  ambiguous,  although  the  data  are consistent  with  either  an  l-J- KAPPLER, SKIDMORE, WHITE, AND MARRACK  1209 
TABLE VIII 
Mapping the H-2 Spedficities of A OFK- 11.1 l. 1 
Strain of  H-2 subregions 
antigen-  H-2  I 
presenting 
cells  K  A  B  J  E  C  S  G 
IL-2 production 
Alone  + OVA  + KLH  D 
BI0.BR  k  k  k  k  k  k  k  k  k  k  -  +  - 
B10  b  b  b  b  b  b  b  b  b  b  +  +  + 
B10.D2  d  d  d  d  d  d  d  d  d  d  -  -  - 
BIO.S  s  s  s  s  s  s  s  s  s  s  -  -  - 
B10.M  f  f  f  f  f  f  f  f  f  f  -  -  + 
B10.A  a  k  k  k  k  k  d  d  d  d  -  + 
B10.A(4R)  h4  k  k  b  b  b  b  b  b  b  -  + 
B 10.AQR  yl  q  k  k  k  k  d  d  d  d  -  + 
BI0.TL  tl  s  k  k  k  k  k  k  k  d  -  + 
D 
m 
m 
a 
B 10.A(3R)  i3  b  b  b  b  k  d  d  d  d  +  +  + 
B10.A(5R)  i5  b  b  b  k  k  d  d  d  d  +  +  + 
B. 10S(TR)  t2  s  s  s  s  s  s  s  s  d 
B10.HTT  t3  s  s  s  s  k  k  k  k  d 
B10.LG  arl  d  f  f  f  f  f  f  f  ? 
B 
SN were tested at 80% with HT-2. OVA concentration:  1,250 #g/ml. KLH concentration:  1,000 pg/ml. 
11-2 subregion assignments are from Klein et al. (47). 
I-E molecule or a  molecule with one chain from I-A and one from I-E/C as the actual 
restricting element  (46). Future experiments testing complementation in appropriate 
F1 mice [e.g., (D2.GD ×  B 10.A)F1] should confirm or reject this possibility. 
These  hybrids  and  others  produced  similarly should  prove  extremely  useful  in 
determining the nature of the receptor(s) on H-2-recognizing T  cells. In this regard, 
they offer a  number of advantages over continuous lines of normal T  cells propagated 
using repeated antigenic stimulation and/or  IL-2 as a  growth factor (27-30).  These 
hybrids  grow  constitutively without  antigenic stimulation  or  growth  factors.  They 
have  doubling  times  of about  12  h  and  grow  in  a  variety of media.  Preliminary 
experiments have shown  that  they can be adapted for ascitic growth in vivo. These 
properties should make it possible to produce easily large numbers of the hybrid cells 
for biochemical characterization. Also, the ease with which these cells can be grown 
and manipulated in vitro has made them particularly useful in genetic experiments 
in which  the behavior of their receptor can be examined  after multiple clonings or 
subsequent  fusions to other cells. 
The reactivity of the hybrid, AO-40.10, both for OVA  plus self I-A k and for allo- 
H-2 b is of particular interest. There is considerable controversy over the question of 
the origin of T  cells that  recognize allo-H-2 antigens.  Some  have suggested  that  T 
cells with these specificities arise as a  fortuitous cross-reaction in which the combina- 
tion of self H-2 and  a  particular antigen  is mimicked by an allo-H-2 antigen  (6-8). 
Others  have  suggested  that  these  two  types  of recognition  are  for  the  most  part 
mutually exclusive, arising from different germline genes (5, 9, 48). There are indeed 
a  few reports supporting in part the former hypothesis, in which T  cell lines or clones 
selected for a  particular self H-2 plus antigen specificity have been found to have an 1210  T  CELL HYBRIDS WITH ONE OR TWO ANTIGEN/H-2 SPECIFICITIES 
allo-H-2 reaction as well  (6-8, 29, 49).  AO-40.10  appears to be another example of 
this type. In this case, one would postulate that the OVA plus I-A k-specific receptor(s) 
obtained from the normal B 10.A parent in the fusion was also capable of recognizing 
a  product  of H-2 b.  In support  of this  view is  the  finding that  all subclones of AO- 
40.10  that  have  been  examined  so  far  demonstrate  both  specificities  or  neither 
specificity, i.e., the genes controlling the two specificities apparently segregate together. 
However, it should be kept in mind that the T  cell tumor parent, FS6-14.13.AG2, was 
derived  from a  fusion  between  BW5147  (an  AKR  thymoma)  and  BDF1  (H-2 n  × 
H-2 a)  normal T  cells (42).  Although  FS6-14.13.AG2  does not react with H-2 b itself, 
it may have inherited a receptor from its normal T  cell parent, with specificity for H- 
2 b plus some unknown antigen (X). It is therefore possible that part of the anti-H-2 b 
receptor of AO40.10  is derived from this, H-2 b plus X, receptor. Our future experi- 
ments will test this possibility. 
In this report we also demonstrated that T  cell hybrids could be constructed from 
two parents with different antigen/H-2  specificities. Many of these hybrids responded 
to  both  parental  antigen/H-2  combinations,  but  no  hybrids  were  detected  that 
displayed a new specificity constructed from the antigen specificity of one parent and 
the H-2  specificity of the other.  These results are clearly inconsistent  with  the two 
receptor models for dual recognition in which the recognition of  antigen is independent 
of the  recognition  of H-2  (17-19,  20,  22,  23).  On  the other  hand,  these results  are 
consistent with most models for dual recognition in which the recognition of antigen 
and H-2 are dependent  on one another.  For example, any single receptor model in 
which a complex T  cell receptor recognizes the combination of antigen and H-2 would 
predict  that  the  specificities  for  antigen  and  H-2  would  not  mix  in  these  doubly 
specific hybrids (24-26).  However, also consistent with these results would be models 
for dual recognition in which an interaction between antigen and an H-2 molecule in 
antigen-presenting cells determines the actual antigenic unit presented to the T  cell, 
because one could not predict that a given antigen would interact with the products 
of one  H-2  haplotype  in  the  same way  as  with  a  second  H-2  haplotype  (23,  25). 
Distinguishing among these various models will have to await a more direct biochem- 
ical characterization of the receptor on these T  cells. 
The cloned doubly specific hybrid AOFK-11.1t.1  responded  to Con  A  (data not 
shown), H-2 b, OVA +  H-2 a'k, and KLH plus H-2 t. The response to OVA was mapped 
to  I-A k  by  the  combination  of genetic  mapping with  H-2  recombinant  mice  and 
inhibition of the response with I-A hybridoma antibodies. The response to KLH was 
mapped to I-A f  using hybridoma antibody inhibition,  but surprisingly, no response 
was seen with cells from B10.LG mice, a strain thought to have an I  region derived 
from H-2 t. This finding is perhaps explicable if one considers the origins of the B 10.LG 
mouse  (C.  David,  personal  communication).  Originally,  the  LG/J  mouse  was  an 
inbred strain developed for large body size. It was typed as H-2 a. Subsequently, Dr. 
Chai of The Jackson Laboratory crossed this strain to an unknown stock to develop 
the H-2 recombinant strain, LG/ckJ, whose H-2 genes (H-2 art) were then placed on 
the B10 background to produce the B 10.LG strain. We obtained this strain from Dr. 
C. David. The assignment of the I  region of H-2 t to H-2 °~t was done on the basis of 
serological typing with anti-Ia antibodies rather than by its known derivation from a 
H-2 t  mouse. An additional  disquieting  feature about the H-2 haplotype of B10.LG 
animals  is  the  fact  that  its  D  region  has  yet  to  be  assigned  and  its  type remains KAPPLER, SKIDMORE, WHITE, AND MARRACK  1211 
unknown. Therefore, it is quite possible that, although they are similar, the I-A regions 
of H-2  ~1  and H-2  t  differ somewhat, including a  difference in the restricting deter- 
minant recognized by AOFK-11.11. I. A second possibility is that the I-A molecules 
from H-2  t  and  H-2 a~  are  identical,  but  that  the  availability  of the  determinant 
recognized by AOFK- 11.11.1  is influenced by D and/or K region products expressed 
on the surface of the antigen-presenting cells. This possibility is not unlikely in light 
of the recent work by Emerson et al. (50) on the influence of one H-2 product on the 
relative expression of other H-2 products. 
Summary 
We developed a  method for production of antigen-specific, H-2-restricted T  cell 
hybrids.  The  tumor  cell  partner  in  the  fusions  was  itself a  T  cell  hybrid,  FS6- 
14.13.AG2 (or its derivatives), which could be induced to produce the growth factor, 
interleukin-2  (IL-2), in  response to  a  challenge  with  concanavalin  A,  but  had  no 
known antigen specificity. The normal T  cell partner in the fusions was a population 
of lymph node T  cell blasts that had been highly enriched in antigen-specific, H-2- 
restricted T  cells by in vivo immunization, followed by in vitro challenge with antigen 
and  clonal expansion  in  IL-2-eontaining medium.  These fusions produced hybrids 
that grew constitutively in culture. A sizable proportion of the hybrids demonstrated 
the ability to produce IL-2 in response to a challenge with specific antigen presented 
by irradiated spleen cells of the appropriate H-2 type. 
Four cloned antigen/H-2-specific  hybrid lines were produced. AO-40.10 responded 
to chicken ovalbumin  (OVA)  when  presented  by /-Ak-bearing cells.  DC1.18.3  re- 
sponded to the apo form of beef cytochrome c when presented with LA d. AODK-10.4 
responded to keyhole limpet hemocyanin (KLH) presented with I-A a. AODK-1.16 
also responded to KLH presented by a product of the I region of H-2  d, but the data 
were  consistent  with  either  a  product  of the  I-J-LE d  region  or  a  combinatorial 
molecule with elements from both I-A d and LEd/I-C a. Coincidentally, AO-40.10 was 
shown to have an unexpected alloreactivity with a  product of H-2 b mapping to the 
K-I-A region. These hybrids should prove invaluable as sources ofmonoclonal material 
for the study of the receptor(s) on T  cells with H-2-restrieted antigen specificities. 
We also generated T  cell hybrids with two antigen~H-2 specificities by fusing an 
azaguanine-resistant  clone of AO-40.10 to normal T  cells with a  different antigen/ 
H-2 specificity. Many of the hybrids retained reactivity to OVA plus H-2 a and to the 
second antigen/H-2 combination. None reacted to either OVA plus the second H-2 
type or to the second antigen plus H-2 ~. 
One of these hybrids was successfully cloned to produce the line AOFK-11.11.1. It 
retained the ability to recognize OVA plus I-A k inherited from one parent, and KLH 
plus LA t inherited from the other. It did not recognize OVA plus LA t or KLH plus 
I-A k. 
These results have some bearing on models describing the nature ofT cell receptors 
for antigen recognized in association with H-2 products. They do not support models 
in  which  antigen  and  H-2  are  recognized  separately  by  two  independent  T  cell 
receptors. 
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